Broadfoot Jill Marie

Broadfoot Jill Marie is listed in filings as Chief Financial Officer at aTyr Pharma, Inc.. This profile follows SEC Form 4 activity through Feb 4, 2026, including sale activity. Recent filings connect the profile to aTyr Pharma, Inc. (ATYR), Cue Biopharma, Inc. (CUE), and Talphera, Inc. (TLPH). The current snapshot covers public activity from Jun 24, 2024 to Feb 4, 2026. Reported amounts are shown as $1.5K to $8.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.